Form 4: Establishment Labs Director Acquires Shares in Lieu of Cash Retainer

Sentiment:

SEC Form 4 Filing


Director Dennis E. Condon acquired 294 common shares of Establishment Labs Holdings Inc. in lieu of a quarterly cash retainer payment on March 31, 2024.

Summary

  • On March 31, 2024, Dennis E. Condon, a director of Establishment Labs Holdings Inc., acquired 294 common shares.
  • The acquisition was in lieu of a quarterly cash retainer payment, as per the Issuer's Outside Director Compensation Policy.
  • The shares were issued under the Issuer's 2018 Equity Incentive Plan.
  • The price was determined based on the closing price of the Issuer's common shares on the last trading day of the quarter, at $50.9 per share.
  • Following the transaction, Condon directly owns 6,121 common shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director is taking shares instead of cash, indicating confidence. However, the transaction is relatively small and part of a pre-existing compensation plan.

Positives

  • The director's decision to take shares instead of cash may signal confidence in the company's future prospects.

Industry Context

Insider transactions are closely watched as they can provide insights into management's perspective on the company's valuation and future prospects. A director accepting shares in lieu of cash compensation can be seen as a positive signal.

Comparison to Industry Standards

  • Director compensation structures vary across the industry, but equity-based compensation is a common practice to align the interests of directors with those of shareholders.
  • Comparing the percentage of equity-based compensation to total compensation for directors at similar-sized medical device companies (e.g., InMode, Cutera) could provide a benchmark for Establishment Labs' approach.

Related Party Transactions

  • The acquisition of shares by the director in lieu of a cash retainer payment is a related party transaction.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

DateDescription
03/31/2024Date of transaction: acquisition of common shares.
04/02/2024Date of signature by Rajbir S. Denhoy, Chief Financial Officer, by power of attorney.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.